Sapreme Appoints CEO, BoD Chair and SAB to Advance Development of Next-Generation RNA Therapeutics for Genetically Driven Diseases
Bilthoven, The Netherlands, May 28, 2024 – Sapreme, a biotechnology company focused on developing next-generation RNA therapeutics for patients with […]